Table 2. Dosimetry Results Calculated by OLINDA/EXM.
| Average | Std Dev | COV | 95% CI (lower upper) | ||||||
| mSv/MBq | rem/mCi | mSv/MBq | rem/mCi | mSv/MBq | rem/mCi | ||||
| Adrenals | 7.41E-01 | 2.74E+00 | 4.00E-02 | 1.47E-01 | 5.40% | 7.13E-01 | 7.69E-01 | 2.64E+00 | 2.84E+00 |
| Brain | 5.86E-01 | 2.17E+00 | 3.38E-02 | 1.26E-01 | 5.80% | 5.63E-01 | 6.09E-01 | 2.08E+00 | 2.26E+00 |
| Breasts | 5.61E-01 | 2.08E+00 | 2.93E-02 | 1.07E-01 | 5.20% | 5.41E-01 | 5.81E-01 | 2.01E+00 | 2.15E+00 |
| Gallbladder Wall | 7.74E-01 | 2.86E+00 | 3.53E-02 | 1.29E-01 | 4.60% | 7.50E-01 | 7.98E-01 | 2.77E+00 | 2.95E+00 |
| LLI Wall | 8.88E-01 | 3.28E+00 | 2.35E-01 | 8.64E-01 | 26.50% | 7.25E-01 | 1.05E+00 | 2.68E+00 | 3.88E+00 |
| Small Intestine | 7.42E-01 | 2.75E+00 | 3.60E-02 | 1.32E-01 | 4.80% | 7.17E-01 | 7.67E-01 | 2.66E+00 | 2.84E+00 |
| Stomach Wall | 7.11E-01 | 2.63E+00 | 3.50E-02 | 1.31E-01 | 4.90% | 6.87E-01 | 7.35E-01 | 2.54E+00 | 2.72E+00 |
| ULI Wall | 7.81E-01 | 2.89E+00 | 7.91E-02 | 2.94E-01 | 10.10% | 7.26E-01 | 8.36E-01 | 2.69E+00 | 3.09E+00 |
| Heart Wall | 7.11E-01 | 2.63E+00 | 3.49E-02 | 1.29E-01 | 4.90% | 6.87E-01 | 7.35E-01 | 2.54E+00 | 2.72E+00 |
| Kidneys (all subjects) | 1.05E+00 | 3.90E+00 | 9.83E-01 | 3.65E+00 | 93.30% | 3.69E-01 | 1.73E+00 | 1.37E+00 | 6.43E+00 |
| Kidneys (excluding 301) | 7.11E-01 | 2.63E+00 | 1.81E-01 | 6.71E-01 | 25.40% | 5.77E-01 | 8.45E-01 | 2.13E+00 | 3.13E+00 |
| Liver | 1.09E+00 | 4.03E+00 | 3.29E-01 | 1.22E+00 | 30.30% | 8.62E-01 | 1.32E+00 | 3.18E+00 | 4.88E+00 |
| Lungs | 9.28E-01 | 3.43E+00 | 4.48E-01 | 1.65E+00 | 48.30% | 6.18E-01 | 1.24E+00 | 2.29E+00 | 4.57E+00 |
| Muscle | 6.29E-01 | 2.33E+00 | 3.26E-02 | 1.21E-01 | 5.20% | 6.06E-01 | 6.52E-01 | 2.25E+00 | 2.41E+00 |
| Ovaries | 7.35E-01 | 2.72E+00 | 4.08E-02 | 1.52E-01 | 5.50% | 7.07E-01 | 7.63E-01 | 2.61E+00 | 2.83E+00 |
| Pancreas | 7.72E-01 | 2.86E+00 | 4.17E-02 | 1.55E-01 | 5.40% | 7.43E-01 | 8.01E-01 | 2.75E+00 | 2.97E+00 |
| Red Marrow | 5.63E-01 | 2.09E+00 | 2.80E-02 | 1.04E-01 | 5.00% | 5.44E-01 | 5.82E-01 | 2.02E+00 | 2.16E+00 |
| Osteogenic Cells | 1.29E+00 | 4.77E+00 | 7.12E-02 | 2.63E-01 | 5.50% | 1.24E+00 | 1.34E+00 | 4.59E+00 | 4.95E+00 |
| Skin | 5.33E-01 | 1.97E+00 | 2.90E-02 | 1.06E-01 | 5.40% | 5.13E-01 | 5.53E-01 | 1.90E+00 | 2.04E+00 |
| Spleen | 1.60E+00 | 5.93E+00 | 8.52E-01 | 3.14E+00 | 53.10% | 1.01E+00 | 2.19E+00 | 3.75E+00 | 8.11E+00 |
| Testes | 6.20E-01 | 2.30E+00 | 3.57E-02 | 1.34E-01 | 5.70% | 5.95E-01 | 6.45E-01 | 2.21E+00 | 2.39E+00 |
| Thymus | 6.59E-01 | 2.44E+00 | 3.47E-02 | 1.27E-01 | 5.30% | 6.35E-01 | 6.83E-01 | 2.35E+00 | 2.53E+00 |
| Thyroid | 6.52E-01 | 2.41E+00 | 3.68E-02 | 1.35E-01 | 5.70% | 6.26E-01 | 6.78E-01 | 2.32E+00 | 2.50E+00 |
| Urinary Bladder Wall | 7.10E-01 | 2.63E+00 | 3.61E-02 | 1.35E-01 | 5.10% | 6.85E-01 | 7.35E-01 | 2.54E+00 | 2.72E+00 |
| Uterus | 7.35E-01 | 2.72E+00 | 4.15E-02 | 1.54E-01 | 5.70% | 7.06E-01 | 7.64E-01 | 2.61E+00 | 2.83E+00 |
| Total Body | 6.69E-01 | 2.47E+00 | 3.21E-02 | 1.18E-01 | 4.80% | 6.47E-01 | 6.91E-01 | 2.39E+00 | 2.55E+00 |
| Effective Dose | 7.41E-01 | 2.74E+00 | 9.74E-02 | 3.59E-01 | 13.20% | 6.74E-01 | 8.08E-01 | 2.49E+00 | 2.99E+00 |
The table shows the statistical summary of the eight subjects' dosimetry calculations.